Literature DB >> 27168465

Is there consensus on consensus?

J-J Kiladjian1,2, R P Gale3.   

Abstract

Mesh:

Year:  2016        PMID: 27168465     DOI: 10.1038/leu.2016.38

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

Review 1.  Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Authors:  N M Kröger; J H Deeg; E Olavarria; D Niederwieser; A Bacigalupo; T Barbui; A Rambaldi; R Mesa; A Tefferi; M Griesshammer; V Gupta; C Harrison; H Alchalby; A M Vannucchi; F Cervantes; M Robin; M Ditschkowski; V Fauble; D McLornan; K Ballen; U R Popat; F Passamonti; D Rondelli; G Barosi
Journal:  Leukemia       Date:  2015-08-21       Impact factor: 11.528

2.  JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms.

Authors:  Sowmya Parampalli Yajnanarayana; Thomas Stübig; Isabelle Cornez; Haefaa Alchalby; Kathrin Schönberg; Janna Rudolph; Ioanna Triviai; Christine Wolschke; Annkristin Heine; Peter Brossart; Nicolaus Kröger; Dominik Wolf
Journal:  Br J Haematol       Date:  2015-03-30       Impact factor: 6.998

3.  Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis.

Authors:  John Koreth; Joseph Pidala; Waleska S Perez; H Joachim Deeg; Guillermo Garcia-Manero; Luca Malcovati; Mario Cazzola; Sophie Park; Raphael Itzykson; Lionel Ades; Pierre Fenaux; Martin Jadersten; Eva Hellstrom-Lindberg; Robert Peter Gale; C L Beach; Stephanie J Lee; Mary M Horowitz; Peter L Greenberg; Martin S Tallman; John F DiPersio; Donald Bunjes; Daniel J Weisdorf; Corey Cutler
Journal:  J Clin Oncol       Date:  2013-06-24       Impact factor: 44.544

4.  JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms.

Authors:  Kathrin Schönberg; Janna Rudolph; Maria Vonnahme; Sowmya Parampalli Yajnanarayana; Isabelle Cornez; Maryam Hejazi; Angela R Manser; Markus Uhrberg; Walter Verbeek; Steffen Koschmieder; Tim H Brümmendorf; Peter Brossart; Annkristin Heine; Dominik Wolf
Journal:  Cancer Res       Date:  2015-04-01       Impact factor: 12.701

5.  Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer.

Authors:  R P Gale; R E Park; R Dubois; J D Bitran; A Buzdar; G Hortobagyi; S E Jones; G S Lazar; G Spitzer; S M Swain; C B Vaughn; C E Vogel; S Martino
Journal:  Clin Transplant       Date:  2000-02       Impact factor: 2.863

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.